Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International, Multicenter, Non-Randomized, Open-Labeled Study to Evaluate the Efficacy of Lower Dose Dexamethasone/Thalidomide and Higher Frequency ZOMETA(TM) in the Treatment of Previously Untreated Patients With Multiple Myeloma

NCT00263484 is registered in ClinicalTrials.gov with Gleneagles Hospital as lead sponsor.

NCT NCT00263484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00263484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International, Multicenter, Non-Randomized, Open-Labeled Study to Evaluate the Efficacy of Lower Dose Dexamethasone/Thalidomide and Higher Frequency ZOMETA(TM) in the Treatment of Previously Untreated Patients With Multiple Myeloma
Lead sponsor
Gleneagles Hospital
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2005
Completion date
October 31, 2010
Enrollment
56 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma